MR7 Super 700000: Dietary supplement for male enhancement — FDA announcement Dec 16, 2025

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Dec 16, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Dietary supplement for male enhancement
Reason
Undeclared Sildenafil and Tadalafil
Classification
Not supplied
Recalling firm
StuffbyNainax LLC
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
b2f8f3b6a76265b5

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityThe tainted MR.7 SUPER 700000 capsules are marketed as a dietary supplement for male enhancement. The affected product does not have lot numbers or expiration dates. The product was distributed nationwide in the United States to a limited number of online customers between August 2025 and November 2025.; Product Name: MR.7 SUPER 700000 Brand: MR.7 Form: Capsules Lot Number: Not available / unlisted Distribution Period: August 2025 – November 2025 Distribution: Sold online in the United States

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The tainted MR.7 SUPER 700000 capsules are marketed as a dietary supplement for male enhancement. The affected product does not have lot numbers or expiration dates. The product was distributed nationwide in the United States to a limited number of online customers between August 2025 and November 2025.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Fda listing date
Dec 16, 2025
Company announcement date
Dec 15, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records